Darin E. Jones - Concepedia

Author

Darin E. Jones

Also Known As

D E JONES, D E Jones, D. E. JONES, D. E. Jones, D. Elfyn Jones, D.E Jones, D.E. Jones, D.E.G. Jones, D.E.J. Jones, D. Elfyn Jones

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Missouri University of Arkansas for Medical Sciences University of Arkansas at Little Rock The University of Texas MD Anderson Cancer Center Washington University in St. Louis

About

Darin E. Jones is an author at University of Missouri specializing in chemistry, organic chemistry, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	11	12	287
2	Natural Sciences	11	11	423
3	Medicine	9	9	407
4	Biochemistry	9	9	379
5	Biomolecular Engineering	8	8	227

Darin E. Jones

Publications

Citations

H-Index

Page 1

	Year	Citations
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death Jerry H. Houl, Zu Ye, Chris A. Brosey, Nature Communications	2019	122
Cloning and complete nucleotide sequence of a full-length cDNA encoding a catalytically functional tumor-associated aldehyde dehydrogenase. Darin E. Jones, M D Brennan, J Hempel, Proceedings of the National Academy of Sciences Full-length CdnaMolecular BiologyDimeric EnzymeTumor BiologyBiochemical Genetics	1988	90
Design, Parallel Synthesis, and Crystal Structures of Pyrazinone Antithrombotics as Selective Inhibitors of the Tissue Factor VIIa Complex John J. Parlow, Brenda L. Case, Thomas A. Dice, Journal of Medicinal Chemistry Combinatorial ChemistryCrystal StructurePharmacotherapyParallel SynthesisChemical Biology	2003	71
Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation Graciela B. Arhancet, Daniel P. Walker, Sue Metz, Bioorganic & Medicinal Chemistry Letters InflammationBioavailable Mpges-1 InhibitorAnti-inflammatoryMedicineImmunology	2012	48
Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer Zhenfu Han, Peter K. Harris, Darin E. Jones, ACS Medicinal Chemistry Letters Kinetic EnzymePathologyHgfa InhibitorsCancer BiologyPharmaceutical Chemistry	2014	45
Intramolecular 4+3 cycloadditions. Vinylthionium ions from allylic alcohols Michael Harmata, Darin E. Jones Tetrahedron Letters Organic ChemistryHeterocycle ChemistryChemistryAllylic Alcohols	1996	43
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex Michael S. South, Brenda L. Case, Rhonda S. Wood, Bioorganic & Medicinal Chemistry Letters Pyrazinone AntithromboticsBiochemistryMedicineNatural SciencesRational Drug Design	2003	42
Intramolecular [4+3] Cycloadditions. Studies of Relative Asymmetric Induction Michael Harmata, Chandra B. Gamlath, Charles L. Barnes, The Journal of Organic Chemistry EngineeringChemical AnalysisAltmetric Attention ScoreMolecular BiologyOrganic Chemistry	1995	40
Vinyl Oxocarbenium Ions in Intermolecular [4 + 3] Cycloaddition Reactions Michael Harmata, Darin E. Jones The Journal of Organic Chemistry Chemical EngineeringEngineeringHeterocyclicOrganic ChemistryVinyl Oxocarbenium Ions	1997	39
Chiral cations in 4+3 cycloadditions Michael Harmata, Darin E. Jones, Mehmet Kahraman, Tetrahedron Letters HeterocyclicOrganic ChemistryChiral CationsChemistryHeterocycle Chemistry	1999	36

Page 1